Incidence and Prevalence of Coronavirus Disease 2019 Within a Healthcare Worker Cohort During the First Year of the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic

Author:

Doernberg Sarah B1,Holubar Marisa2ORCID,Jain Vivek3,Weng Yingjie4,Lu Di4,Bollyky Jenna B5,Sample Hannah6,Huang Beatrice7,Craik Charles S8,Desai Manisha4,Rutherford George W9,Maldonado Yvonne5,Bhargava Parul,Bohn Markus,Chao Jessica,Craik Charles S,Doernberg Sarah B,Ghahremani Jacob,Glidden David,Gonzales Ralph,Huang Beatrice,Jaladanki Sravya,Julien Aida,Lowenstein Daniel,Miller Steve,Mustoe Audrey,Paoletti Marcus,Rutherford George W,Sample Hannah,Villa Rodolfo,Wan Emerald,Williams Aimee,Brown Lillian,Chuang Jessica,Jain Vivek,Marquez Carina,Padda Guntas,Rubio Luis,Valdivieso Daisy,Abad Rosebay,Bet Anthony,Bollyky Jenna,Desai Manisha,Fung Jeffrey,Graber Anna,Holderman Cole,Holubar Marisa,Kelley Hannah,Kempema Amanda,Kong Christina,Leung Christopher,Lohmann Joseph,Lu Di,Maldonado Yvonne,Minor Lloyd,Orozco Lorena,Pinsky Benjamin A,Saxeena Jamie,Sklar Matthew,Tang Hilary,Wiese Jasmine,Weng Yingjie,Crawford Emily,DeRisi Joe,

Affiliation:

1. Division of Infectious Diseases, University of California, San Francisco , San Francisco, California , USA

2. Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine , Stanford, California , USA

3. Division of HIV, Infectious Diseases & Global Medicine, San Francisco General Hospital, University of California, San Francisco , San Francisco, California , USA

4. Quantitative Sciences Unit, Stanford University School of Medicine , California , USA

5. Division of Pediatric Infectious Diseases, Stanford University School of Medicine , California , USA

6. Department of Biochemistry and Biophysics, University of California, San Francisco , San Francisco, California , USA

7. Department of Family and Community Medicine, San Francisco General Hospital, University of California, San Francisco , San Francisco, California , USA

8. Department of Pharmaceutical Chemistry, University of California, San Francisco , San Francisco, California , USA

9. Division of Infectious Disease and Global Epidemiology, Department of Epidemiology and Biostatistics, University of California, San Francisco , San Francisco, California , USA

Abstract

Abstract Background Preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2_ infections in healthcare workers (HCWs) is critical for healthcare delivery. We aimed to estimate and characterize the prevalence and incidence of coronavirus disease 2019 (COVID-19) in a US HCW cohort and to identify risk factors associated with infection. Methods We conducted a longitudinal cohort study of HCWs at 3 Bay Area medical centers using serial surveys and SARS-CoV-2 viral and orthogonal serological testing, including measurement of neutralizing antibodies. We estimated baseline prevalence and cumulative incidence of COVID-19. We performed multivariable Cox proportional hazards models to estimate associations of baseline factors with incident infections and evaluated the impact of time-varying exposures on time to COVID-19 using marginal structural models. Results A total of 2435 HCWs contributed 768 person-years of follow-up time. We identified 21 of 2435 individuals with prevalent infection, resulting in a baseline prevalence of 0.86% (95% confidence interval [CI], .53%–1.32%). We identified 70 of 2414 incident infections (2.9%), yielding a cumulative incidence rate of 9.11 cases per 100 person-years (95% CI, 7.11–11.52). Community contact with a known COVID-19 case was most strongly correlated with increased hazard for infection (hazard ratio, 8.1 [95% CI, 3.8–17.5]). High-risk work-related exposures (ie, breach in protective measures) drove an association between work exposure and infection (hazard ratio, 2.5 [95% CI, 1.3–4.8). More cases were identified in HCWs when community case rates were high. Conclusions We observed modest COVID-19 incidence despite consistent exposure at work. Community contact was strongly associated with infections, but contact at work was not unless accompanied by high-risk exposure.

Funder

Chan Zuckerberg Initiative Foundation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3